مراجعة
Reducing myocardial infarct size: Challenges and future opportunities
العنوان: | Reducing myocardial infarct size: Challenges and future opportunities |
---|---|
المؤلفون: | Bulluck, H, Yellon, D.M, Hausenloy, D.J |
المساهمون: | DUKE-NUS MEDICAL SCHOOL |
المصدر: | Unpaywall 20201031 |
بيانات النشر: | BMJ Publishing Group |
سنة النشر: | 2016 |
المجموعة: | National University of Singapore: ScholarBank@NUS |
مصطلحات موضوعية: | adenosine, antiinflammatory agent, antioxidant, atorvastatin, atrial natriuretic factor, atrial natriuretic factor alpha, calcium channel blocking agent, cyclosporin A, delcasertib, elamipretide, erythropoietin, exendin 4, glucose, insulin, magnesium, metoprolol, nitric oxide, placebo, potassium, protein inhibitor, sodium nitrite, tro 40303, unclassified drug, cardiovascular agent, acute heart infarction, death, drug effect, drug efficacy, drug mechanism, drug targeting |
الوصف: | 10.1136/heartjnl-2015-307855 ; Heart ; 102 ; 5 ; 341-348 |
نوع الوثيقة: | review |
اللغة: | unknown |
تدمد: | 1355-6037 |
العلاقة: | Bulluck, H, Yellon, D.M, Hausenloy, D.J (2016). Reducing myocardial infarct size: Challenges and future opportunities. Heart 102 (5) : 341-348. ScholarBank@NUS Repository. https://doi.org/10.1136/heartjnl-2015-307855Test; https://scholarbank.nus.edu.sg/handle/10635/179591Test |
الإتاحة: | https://doi.org/10.1136/heartjnl-2015-307855Test https://scholarbank.nus.edu.sg/handle/10635/179591Test |
حقوق: | Attribution 4.0 International ; http://creativecommons.org/licenses/by/4.0Test/ |
رقم الانضمام: | edsbas.BBB52704 |
قاعدة البيانات: | BASE |
تدمد: | 13556037 |
---|